Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for iSpecimen Inc. (ISPC : NSDQ)

• Company Description    iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass. Number of Employees: 59

• Price / Volume Information    Yesterday's Closing Price: $2.53 Daily Weekly Monthly 20 Day Moving Average: 135,475 shares Shares Outstanding: 8.82 (millions) Market Capitalization: $22.31 (millions) Beta: 52 Week High: $28.98 52 Week Low: $2.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -34.12% -30.21% 12 Week -39.04% -33.39% Year To Date -67.61% -60.83%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 450 BEDFORD STREET SUITE 1010 - LEXINGTON,MA 02420 USA ph: 781-301-6700 fax: - ispecimen@kcsa.com http://www.ispecimen.com

• General Corporate Information    Officers Christopher Ianelli - Chief Executive Officer; President Andrew L. Ross - Chairman of the Board Jill Mullan - Chief Operating Officer; Secretary and Director Tracy Curley - Chief Financial Officer and Treasurer Steven Gullans - Director Peer Information iSpecimen Inc. (CHCR) iSpecimen Inc. (ESRX) iSpecimen Inc. (MYDP) iSpecimen Inc. (GBCS) iSpecimen Inc. (LAXAF) iSpecimen Inc. (IPCM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 45032V108 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/09/22 Share - Related Items Shares Outstanding: 8.82 Most Recent Split Date: (:1) Beta: Market Capitalization: $22.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/09/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.81 Price/Cash Flow: - Price / Sales: 2.09 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -1.14% ROE 03/31/22 - -36.81 12/31/21 - -68.20 09/30/21 - - ROA 03/31/22 - -27.80 12/31/21 - -49.14 09/30/21 - - Current Ratio 03/31/22 - 14.73 12/31/21 - 13.15 09/30/21 - 7.08 Quick Ratio 03/31/22 - 14.73 12/31/21 - 13.15 09/30/21 - 7.08 Operating Margin 03/31/22 - -69.07 12/31/21 - -80.49 09/30/21 - - Net Margin 03/31/22 - -69.07 12/31/21 - -80.49 09/30/21 - - Pre-Tax Margin 03/31/22 - -69.07 12/31/21 - -80.49 09/30/21 - - Book Value 03/31/22 - 3.14 12/31/21 - 3.41 09/30/21 - 1.75 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.12 12/31/21 - 0.11 09/30/21 - 0.28 Debt-to-Capital 03/31/22 - 11.02 12/31/21 - 10.31 09/30/21 - 22.09

Powered by Zacks Investment Research ©